In MM, several interleukins, such as IL-6, IL-3, IL-17, IL-1, and IL-11, regulate cell proliferation, survival, and drug resistance, and promote osteolytic lesions, thus underscoring the pathogenetic role of the deregulated immune system in MM. The gene discussed is IL6; the disease is Miyoshi myopathy.